Carregant...
TMIC-26. IMMUNOMODULATION WITH TEMOZOLOMIDE TO IMPROVE EFFICACY OF IMMUNE CHECKPOINT INHIBITION FOR THE TREATMENT OF GLIOBLASTOMA
Immune checkpoint inhibitors are under active investigation as novel strategies for the treatment of newly diagnosed glioblastoma (GBM). Due to the effects of temozolomide (TMZ) on host immunity, we hypothesize that dose and timing of TMZ will impact efficacy of immune checkpoint inhibition with PD-...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692988/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.1015 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|